Disseminated fungal infection in a patient receiving zanubrutinib
Madalyn Walsh, Alice Xu, Zuhair K. Ballas, Rolando Sanchez
Abstract
We report a case of fatal disseminated aspergillosis in the setting of administration of zanubrutinib, a second-generation Bruton's tyrosine kinase inhibitor thought to have a lower rate of immunosuppression-related side effects.
Topics & Concepts
MedicineImmunosuppressionAspergillosisTyrosine-kinase inhibitorTyrosine kinaseIntensive care medicineInternal medicineImmunologyCancerReceptorChronic Lymphocytic Leukemia ResearchAutoimmune Bullous Skin DiseasesCutaneous lymphoproliferative disorders research